Skip to content
FI
EN
SV
Review by the Chief Executive( 2024 )
Operations
Blood Supply
Blood Donation( 2024 )
Blood Products( 2024 )
Laboratory services( 2024 )
Clinical contacts and haemovigilance( 2024 )
Other Operations
Stem Cell Registry( 2024 )
Advanced Cell Therapy Centre( 2024 )
Biobank and sample service( 2024 )
Research( 2024 )
Other operations( 2024 )
Finance and responsibility
Finance
Financial management( 2024 )
Internal profit and loss account( 2024 )
Internal balance sheet( 2024 )
Social Responsibility
Responsibility( 2024 )
Social responsibility indicators( 2024 )
Staff( 2024 )
Management( 2024 )
Previous annual reports
Bloodservice.fi
Previous annual reports
Bloodservice.fi
FI
EN
SV
Review by the Chief Executive( 2024 )
Operations
Blood Supply
Blood Donation( 2024 )
Blood Products( 2024 )
Laboratory services( 2024 )
Clinical contacts and haemovigilance( 2024 )
Other Operations
Stem Cell Registry( 2024 )
Advanced Cell Therapy Centre( 2024 )
Biobank and sample service( 2024 )
Research( 2024 )
Other operations( 2024 )
Finance and responsibility
Finance
Financial management( 2024 )
Internal profit and loss account( 2024 )
Internal balance sheet( 2024 )
Social Responsibility
Responsibility( 2024 )
Social responsibility indicators( 2024 )
Staff( 2024 )
Management( 2024 )
search
search
search
